Natalia Blanco

Natalia Blanco

Company: Morphic Therapeutics

Job title: Associate Director, Immuo-Oncology


Immune-Mediated Effects of the Integrin avb8 Inhibitors to Enhance Antitumor Efficacy 2:30 pm

Activation of TGF-β by αvβ8-expressing cells enhances tumor tolerance αvβ8 inhibition is sufficient to reverse TGF-β-driven immunosuppression αvβ8 inhibition on tumor and/or immune cells impairs regulatory mechanisms while unleashing a potent antitumor immunityRead more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.